ULTRAGENYX PHARMACEUTICAL IN's ticker is RARE and the CUSIP is 90400D108. A total of 237 filers reported holding ULTRAGENYX PHARMACEUTICAL IN in Q1 2022. The put-call ratio across all filers is 2.14 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $393 | -82.6% | 11 | -77.6% | 0.00% | -100.0% |
| Q2 2023 | $2,261 | +52.4% | 49 | +32.4% | 0.00% | – |
| Q1 2023 | $1,484 | +146.5% | 37 | +184.6% | 0.00% | – |
| Q4 2022 | $602 | – | 13 | +8.3% | 0.00% | – |
| Q3 2022 | $0 | -100.0% | 12 | +20.0% | 0.00% | – |
| Q2 2022 | $1,000 | -50.0% | 10 | -61.5% | 0.00% | -100.0% |
| Q4 2021 | $2,000 | +100.0% | 26 | +116.7% | 0.00% | – |
| Q3 2021 | $1,000 | – | 12 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| First Light Asset Management, LLC | 437,512 | $31,772,000 | 2.80% |
| RTW INVESTMENTS, LP | 1,373,284 | $99,728,000 | 2.06% |
| Rock Springs Capital Management LP | 1,028,109 | $74,661,000 | 1.88% |
| Privium Fund Management B.V. | 112,727 | $8,186,000 | 1.81% |
| Avidity Partners Management LP | 869,000 | $63,107,000 | 1.31% |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 525,100 | $38,133,000 | 1.16% |
| Boxer Capital, LLC | 200,000 | $14,524,000 | 0.75% |
| SECTOR GAMMA AS | 46,221 | $3,357,000 | 0.73% |
| FEDERATED HERMES, INC. | 3,987,728 | $289,589,000 | 0.65% |
| EMERALD ADVISERS, LLC | 223,952 | $16,263,000 | 0.62% |